Orthofix Names Andres Cedron as New Chief Legal Officer

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Andres Cedron has joined the company as Chief Legal Officer.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240416821173/en/

Andres Cedron, Chief Legal Officer for Orthofix (Photo: Business Wire)

Cedron most recently served as Vice President and Corporate Secretary at Stryker Corporation, a $20B+ global medical device company. In his corporate officer position, Cedron oversaw Stryker’s corporate governance, SEC compliance, mergers and acquisitions, and ESG matters.

“With a broad breadth of experience in the medical device industry and legal transactions, Andres is the perfect fit for this important leadership role,” said Massimo Calafiore, President and Chief Executive Officer of Orthofix. “His extensive understanding of our business and the overall market will be an asset in helping the company drive profitability and growth as we continue to power Orthofix’s transformation.”

Cedron is known for his strong focus on scaling businesses and accelerating performance and will lead Orthofix in a broad range of corporate and commercial matters.

“I am thrilled to join such a talented leadership team and organization of dedicated employees,” said Andres Cedron, Chief Legal Officer. “This is an exciting time for the company, and I look forward to helping Orthofix become an even stronger competitor in the market.”

About Andres Cedron

Cedron brings nearly 20 years of executive legal experience to Orthofix. In addition to his role as Vice President and Corporate Secretary at Stryker, Cedron held leadership roles as Chief Legal Counsel for Stryker’s $10B+ MedSurg and Neurotechnology Group, as well as the company’s EMEA and Latin America regions. In addition, Cedron served as President of Stryker’s Hispanic/Latino employee resource group from 2019 to 2022, growing it from two to eight chapters nationally and more than 1,000 members. He has extensive expertise in regulatory and compliance frameworks, anti-corruption programs, litigation management, and commercial legal strategies in the medical device industry.